C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/505 (2006.01)
Patent
CA 2587382
The present invention relates to peptide compounds that are agonists of the erythropoietin receptor (EPO-R). The invention further relates to therapeutic methods using such peptide compounds to treat disorders associated with insufficient or defective red blood cell production. Pharmaceutical compositions, which comprise the peptide compounds of the invention, are also provided.
La présente invention concerne des composés peptidiques qui sont des agonistes du récepteur d'érythropoïétine (EPO-R). L'invention concerne également des procédés thérapeutiques utilisant ces composés peptidiques pour traiter des troubles associés à une production insuffisante ou défectueuse d'érythrocytes. L'invention concerne aussi des compositions pharmaceutiques qui comprennent des composés peptidiques de l'invention.
Bhandari Ashok
Chakrabarti Anjan
Dong Yaohua S.
Dower William J.
Frederick Brian T.
Affymax Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Bhandari Ashok
Chakrabarti Anjan
Dong Yaohua S.
LandOfFree
Novel peptides that bind to the erythropoietin receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel peptides that bind to the erythropoietin receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel peptides that bind to the erythropoietin receptor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1799145